Algeria begins producing the CoronaVac COVID-19 vaccine developed by Sinovac, with expected production of eight million doses per month
Algeria begins producing the CoronaVac COVID-19 vaccine developed by Sinovac, with expected production of eight million doses per month.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthAlgeria begins producing the CoronaVac COVID-19 vaccine developed by Sinovac, with expected production of eight million doses per month
View Premium plansBrowse free archive reportsAlgeria begins producing the CoronaVac COVID-19 vaccine developed by Sinovac, with expected production of eight million doses per month.